Head of Health Partnerships, 23andMe
Biography
Erin leads collaborations with digital health companies, provider organizations, and other healthcare players to advance 23andMe’s health product and strategy. A healthcare nerd with a passion for leveraging technology to solve the industry’s toughest problems, Erin has held a range of business development, corporate development, and product strategy roles at leading health tech companies including Redox, athenahealth, Doximity, and Rock Health. She holds a B.A. from the University of California, Berkeley and an MBA from Harvard Business School.
Wellness & Aging Showcase:
23andMe
23andMe, Inc. is the leading consumer genetics and research company. Founded in 2006, the mission of the company is to help people access, understand and benefit from the human genome.
23andMe: Turning Genetic Information Into Actionable Insights
The 23andMe cohort is the largest re-contactable research database of genotypic and phenotypic information in the world. By inviting customers to participate in research, we have created a new research model that accelerates genetic discovery and offers the potential to more quickly garner new insights into treatments for disease.
Session Abstract – PMWC 2020 Silicon Valley
Track 6 - January 23 1.00 P.M.-4.30 P.M.
The PMWC 2020 Wellness & Aging Showcase will provide a 15-minute time slot for selected companies in Wellness and Aging to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from selected companies that build innovative solutions and harness the power of digital health, genomics, and data science with the goal to proactively prevent disease, maintain optimal health, and slow down aging.
